Design and in vitro characterization of buccoadhesive drug delivery system of insulin

Indian Journal of Pharmaceutical Sciences

Volumn 70, Issue 1, 2008, Pages 61-65

  Sahni, J ^a   Raj, S ^a   Ahmad, F ^a   Khar, R ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Buccoadhesive; Insulin delivery; Protein delivery; Transmucosal

Indexed keywords

2 PROPANOL; BETA CYCLODEXTRIN; CARBOXYMETHYLCELLULOSE; DEOXYCHOLATE SODIUM; DODECYL SULFATE SODIUM; GLYCERYLMONOLAURATE; GLYCOCHOLATE SODIUM; HUMAN INSULIN; LAURATE SODIUM; LAURIC ACID DERIVATIVE; PENETRATION ENHANCING AGENT; PHOSPHATE BUFFERED SALINE; PROPYLENE GLYCOL; SOLVENT; WATER;

ANIMAL TISSUE; ARTICLE; BUCCOADHESIVE DRUG DELIVERYS SYSTEM; CHEEK POUCH; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DIFFUSION; DRUG PENETRATION; DRUG SOLUBILITY; IN VITRO STUDY; MEMBRANE MODEL; NONHUMAN; PH; SKIN PERMEABILITY;

EID: 43449083508     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.40333     Document Type: Article

References (16)

1. Benes L, Claustrat B, Horriere F, Geoffriau M, Konsil J, Parrott KA, et al. Transmucosal, oral controlled release, and transdermal drug administration in human subjects: A crossover study with melatonin. J Pharm Sci 1997;86:1115-9.
2. Cannon JB, Adjei LA, Lu MY, Garren K. Alternate drug delivery routes for A-71623, a potent cholecystokinin-a receptor agonist tetrapeptide. J Drug Targeting 1996;4:69-78.
3. Watanabe Y, Kiriyama M, Ito R, Kikuchi R, Mizufune Y, Nomura H, et al. Pharmacodynamics and pharmacokinetics of recombinant human granulocyte colony-stimulating factor (rhG-CSF) after administration of a rectal dosage vehicle. Biol Pharm Bull 1996;19:1059-63.
4. Harris AS, Ohlin M, Lethagen S, Nilsson IM. Effects of concentration and volume on nasal bioavailability and biological response to desmopressin. J Pharm Sci 1988;77:337-9.
5. Acarturk F, Robinson JR. Vaginal permeability and enzymatic activity studies in normal and ovariectomized rabbits. Pharm Res 1996;13:779-83.
6. Rathbone MJ, Drummond BK, Tucker IG. The oral site as a site for systemic drug delivery. Adv Drug Deliev Rev 1994;13:1-22.7.
7. Chidambaram N, Srivatava AK. Buccal drug delivery systems. Drug Develop Ind Pharm 1995;21:1009-36.
8. Khanna R, Agarwal SP, Ahuja A. Mucoadhesive buccal drug delivery: a potential alternative to conventional therapy. Indian J Pharm Sci 1998;60:1-11.
9. Li C, Koch RL, Raul VA, Bhatt PP, Johnston TP. Absorption of thyrotropin releasing hormone in rats using a mucoadhesive buccal patch. Drug Develop Ind Pharm 1997;23:239-46.
10. Heiber SJ, Ebert CD, Dave SC, Smith K, Kim SW, Mix D. In vivo buccal delivery of calcitonin. J Control Release 1994;28:269-71.
11. Hoogstraate AJ, Verhoef JC, Pijpers A, Van Leengoed LA, Verheijden JH, Junginger HE, et al. In vivo buccal delivery of peptide drug buserelin with glycodeoxycholate as an absorption enhancer in pigs. Pharm Res 1996;13:1233-7.
12. Li C, Bhatt PP, Johnston TP. Transmucosal delivery of oxytocin to rabbits using a mucoadhesive buccal patch. Pharm Develop Technol 1997;2:265-74.
13. Anders R, Merkle HP. Evaluation of laminated muco-adhesive patches for buccal drug delivery. Int J Pharm 1989;49:231-40.
14. Ali J, Khar R, Ahuja A, Kalra R. Buccoadhesive erodible disk for treatment of oro-dental infections: Design and characterization. Int J Pharm 2002;238:93-103.
15. Gupta A, Garg S, Khar RK. Measurement of bioadhesive strength of muco-adhesive buccal tablets: design of an in vitro assembly. Indian drugs 1992;30:152-5.
16. Ahuja A, Dogra M, Agarwal SP. Development of buccal tablets of diltiazem hydrochloride. Indian J Pharm Sci 1995;57:26-30.